A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Appointments and advancements for Feb. 26, 2026
Appointments and advancements for Feb. 26, 2026
Financings for Feb. 26, 2026
Financings for Feb. 26, 2026
In the clinic for Feb. 26, 2026
In the clinic for Feb. 26, 2026
Other news to note for Feb. 26, 2026
Other news to note for Feb. 26, 2026
Regulatory actions for Feb. 26, 2026
Regulatory actions for Feb. 26, 2026
Gan & Lee Pharmaceuticals patents SMARCA2/4-degrading PROTACs
Gan & Lee Pharmaceuticals patents SMARCA2/4-degrading PROTACs
Cathepsin L inhibitors disclosed in Biofront Therapeutics patent
Cathepsin L inhibitors disclosed in Biofront Therapeutics patent
MSD patent details new WRN inhibitors for cancer
MSD patent details new WRN inhibitors for cancer
Retex Pharmaceuticals divulges vasopressin V2 receptor antagonists
Retex Pharmaceuticals divulges vasopressin V2 receptor antagonists
Appointments and advancements for Feb. 25, 2026
Appointments and advancements for Feb. 25, 2026
Financings for Feb. 25, 2026
Financings for Feb. 25, 2026
In the clinic for Feb. 25, 2026
In the clinic for Feb. 25, 2026
Other news to note for Feb. 25, 2026
Other news to note for Feb. 25, 2026
Regulatory actions for Feb. 25, 2026
Regulatory actions for Feb. 25, 2026
Covant Therapeutics patents FcRn antagonists
Covant Therapeutics patents FcRn antagonists
Blossomhill Therapeutics reports new EGFR inhibitors
Blossomhill Therapeutics reports new EGFR inhibitors
PARG inhibitors disclosed in Avelos Therapeutics patent
PARG inhibitors disclosed in Avelos Therapeutics patent
Shanghai Meiyue Biotech patents divulge c-KIT inhibitors
Shanghai Meiyue Biotech patents divulge c-KIT inhibitors
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page